Considerations for safety pharmacogenetics in clinical practice

Drug Discovery Today

Volumn 16, Issue 19-20, 2011, Pages 898-901

  Frueh, Felix W ^a  

^a Medco Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CARBAMAZEPINE; CLOPIDOGREL; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; HEMOGLOBIN A1C; HLA B ANTIGEN; WARFARIN;

BLOOD PRESSURE; BODY TEMPERATURE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DRUG EFFICACY; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; GENETIC MARKER; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; PATIENT SAFETY; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; REVIEW; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; UNSPECIFIED SIDE EFFECT;

CLINICAL MEDICINE; DRUG LABELING; GENETIC MARKERS; GENETIC TESTING; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; SAFETY;

EID: 80053985774     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.08.009     Document Type: Review

References (9)

1. S. Mallal HLA-B*5701 screening for hypersensitivity to abacavir N. Engl. J. Med. 358 2008 568 579
2. S.I. Hung Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions Pharmacogenet. Genomics 16 2006 297 306
3. J.L. Mega Cytochrome p-450 polymorphisms and response to clopidogrel N. Engl. J. Med. 360 2009 354 362
4. R.P. Kreutz Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study Pharmacotherapy 30 2010 787 796
5. J.L. Anderson Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation Circulation 116 2007 2563 2570 (Pubitemid 350179221)
6. R.S. Epstein Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) J. Am. Coll. Cardiol. 55 2010 2804 2812
7. F.W. Frueh Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use Pharmacotherapy 28 2008 992 998
8. J. Lazarou Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies JAMA 279 1998 1200 1205 (Pubitemid 28193431)
9. B.B. Spear Clinical application of pharmacogenetics Trends Mol. Med. 7 2001 201 204 (Pubitemid 32822891)